 |
|
| Research Interests: | Interplay between genome, transcriptome and epigenome |
| Present Position: | Research Professor, Institute of Biotechnology Professor, Vilnius University |
| Education: |
PhD in Biological Chemistry (Kestler Prize for outstanding PhD work) at Institut de Science et d'Ingénierie Supramoléculaires, Université de Strasbourg, France |
| Experience (Past Positions): | 2017–2019 - Associate Member, Sloan Kettering Institute, NY, USA 2017–2019 - Director of Single Cell Research Initiative at Sloan Kettering Institute, NY, USA 2015–2017 - Group Leader, Institute of Biotechnology, LT 2015–2017 - CEO, Droplet Genomics, LT 2015 - Visiting Scientist, Systems Biology, Columbia University, USA 2015 - Visiting Scientist, Biophysics, CALTECH, USA 2014–2015 - CTO, Chief Technology Officer, Platelet Biogenesis Inc., USA 2010–2015 - Postdoctoral fellow, Harvard University, USA |
| Since 2015, Synthetic Biology, MSc programme Since 2020, Systems Biology and Innovations, MSc programme |
|
| Supervision of Doctoral Students: | Present: Lorenzo Camisi Greta Leonavičienė Denis Baronas Justina Žvirblytė Karolis Goda Past: Dr. Juozas Nainys Dr. Rapolas Žilionis Dr. Vaidotas Kiseliovas Dr. Robertas Galinis |
| Awards: | 2019 Rector’s Outstanding Scientist Award, Vilnius University, LT 2017 Global Lithuanian Leaders Award, LT 2017 Lithuanian-American Innovation Award, US 2014 Harvard Innovation Lab Award, US 2014 Milton Shifman Endowed Award, US 2010 Kestler Prize, FR |
| Publications: | LABT_LMAVB GoogleScholar |
| Academic Cooperation: |
Prof. Allon M. Klein, Harvard Medical School, USA https://www.klein.hms.harvard.edu |
|
Projects and Grants: |
H2020-MSCA-ITN-2018, EvoDrops (813786), directed EVOlution in DROPS |
| Other Related Activities: | I am a co-founder of two biotech and biomedical companies: 1. “Platelet BioGenesis Inc”, (Boston, MA) that develops technology for production of the donor-independent platelets from human iPSC, 2. “Droplet Genomics” (Vilnius, LT) that offers commercial solutions for single-cell sequencing and analysis. I have served as an invited expert for various FP7 and H2020 programs (EU), including ERC, National Science Foundation (US), Swiss National Science Foundation, Medical Research Council (UK), La Caxia Foundation (Spain), DIM-ELICIT (France), The French National Research Agency - IRIS ANR (France), MITA (Lithuania). I currently serve as an Editorial Board member of Current Opinion in Biotechnology (Elsevier). |
| Languages: | Lithuanian, English |